Literature DB >> 22547330

Analysis of region-specific changes in gene expression upon treatment with citalopram and desipramine reveals temporal dynamics in response to antidepressant drugs at the transcriptome level.

Magdalena Gąska1, Maciej Kuśmider, Joanna Solich, Agata Faron-Górecka, Małgorzata J Krawczyk, Krzysztof Kułakowski, Marta Dziedzicka-Wasylewska.   

Abstract

RATIONALE: The notion that the onset of action of antidepressant drugs (ADs) takes weeks is widely accepted; however, the sequence of events necessary for therapeutic effects still remains obscure.
OBJECTIVE: We aimed to evaluate a time-course of ADs-induced alterations in the expression of 95 selected genes in 4 regions of the rat brain: the prefrontal and cingulate cortices, the dentate gyrus of the hippocampus, and the amygdala.
METHODS: We employed RT-PCR array to evaluate changes during a time-course (1, 3, 7, 14, and 21 days) of treatments with desipramine (DMI) and citalopram (CIT). In addition to repeated treatment, we also conducted acute treatment (a single dose of drug followed by the same time intervals as the repeated doses).
RESULTS: Time-dependent and structure-specific changes in gene expression patterns allowed us to identify spatiotemporal differences in the molecular action of two ADs. Singular value decomposition analysis revealed differences in the global gene expression profiles between treatment types. The numbers of characteristic modes were generally smaller after CIT treatment than after DMI treatment. Analysis of the dynamics of gene expression revealed that the most significant changes concerned immediate early genes, whose expression was also visualized by in situ hybridization. Transcription factor binding site analysis revealed an over-representation of serum response factor binding sites in the promoters of genes that changed upon treatment with both ADs.
CONCLUSIONS: The observed gene expression patterns were highly dynamic, with oscillations and peaks at various time points of treatment. Our study also revealed novel potential targets of antidepressant action, i.e., Dbp and Id1 genes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547330      PMCID: PMC3438400          DOI: 10.1007/s00213-012-2714-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  71 in total

1.  Some behavioural effects of antidepressant drugs are time-dependent.

Authors:  M Dziedzicka-Wasylewska; Z Rogóz; W Margas; D Dlaboga; M Góralska
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2001-02       Impact factor: 5.067

2.  Dynamic modeling of gene expression data.

Authors:  N S Holter; A Maritan; M Cieplak; N V Fedoroff; J R Banavar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

3.  Gene expression profile analysis of the rat cortex following treatment with imipramine and citalopram.

Authors:  Miklós Palotás; András Palotás; László G Puskás; Klára Kitajka; Magdolna Pákáski; Zoltán Janka; József Molnár; Botond Penke; János Kálmán
Journal:  Int J Neuropsychopharmacol       Date:  2004-07-26       Impact factor: 5.176

Review 4.  New therapeutic targets for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Nancy DiazGranados; Lobna Ibrahim; David Latov; Cristina Wheeler-Castillo; Jacqueline Baumann; Ioline D Henter; Carlos A Zarate
Journal:  ScientificWorldJournal       Date:  2010-04-13

Review 5.  Galanin, galanin receptor subtypes and depression-like behaviour.

Authors:  E Kuteeva; T Hökfelt; T Wardi; S O Ogren
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

6.  Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.

Authors:  B Conti; R Maier; A M Barr; M C Morale; X Lu; P P Sanna; G Bilbe; D Hoyer; T Bartfai
Journal:  Mol Psychiatry       Date:  2006-10-10       Impact factor: 15.992

7.  Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones.

Authors:  G Okugawa; K Omori; J Suzukawa; Y Fujiseki; T Kinoshita; C Inagaki
Journal:  J Neuroendocrinol       Date:  1999-11       Impact factor: 3.627

8.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

Authors:  M Nibuya; S Morinobu; R S Duman
Journal:  J Neurosci       Date:  1995-11       Impact factor: 6.167

9.  Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine.

Authors:  Inge Sillaber; Markus Panhuysen; Markus S H Henniger; Frauke Ohl; Claudia Kühne; Benno Pütz; Thomas Pohl; Jan M Deussing; Marcelo Paez-Pereda; Florian Holsboer
Journal:  Psychopharmacology (Berl)       Date:  2008-07-16       Impact factor: 4.530

10.  Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.

Authors:  M Nibuya; E J Nestler; R S Duman
Journal:  J Neurosci       Date:  1996-04-01       Impact factor: 6.167

View more
  4 in total

1.  MicroRNA Profiling in the Medial and Lateral Habenula of Rats Exposed to the Learned Helplessness Paradigm: Candidate Biomarkers for Susceptibility and Resilience to Inescapable Shock.

Authors:  Katrine Svenningsen; Morten T Venø; Kim Henningsen; Anne S Mallien; Line Jensen; Trine Christensen; Jørgen Kjems; Barbara Vollmayr; Ove Wiborg
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

2.  Differential and converging molecular mechanisms of antidepressants' action in the hippocampal dentate gyrus.

Authors:  Patrícia Patrício; António Mateus-Pinheiro; Martin Irmler; Nuno D Alves; Ana R Machado-Santos; Mónica Morais; Joana S Correia; Michal Korostynski; Marcin Piechota; Rainer Stoffel; Johannes Beckers; João M Bessa; Osborne F X Almeida; Nuno Sousa; Luísa Pinto
Journal:  Neuropsychopharmacology       Date:  2014-07-18       Impact factor: 7.853

3.  Redundant Gs-coupled serotonin receptors regulate amyloid-β metabolism in vivo.

Authors:  Jonathan R Fisher; Clare E Wallace; Danielle L Tripoli; Yvette I Sheline; John R Cirrito
Journal:  Mol Neurodegener       Date:  2016-06-18       Impact factor: 14.195

Review 4.  Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.

Authors:  Emmanuelle A D Schindler; Ryan M Wallace; Jordan A Sloshower; Deepak C D'Souza
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.